Table 2 Representative parameters of the control solution depending on the discount factor ρ
From: The effects of time valuation in cancer optimal therapies: a study of chronic myeloid leukemia
ρ | 1 | 0.9 | 0.8 | 0.7 | 0.65 |
|---|---|---|---|---|---|
Tmax (days) | 850 | 829 | 816 | 806 | 801 |
UTot (mg) | 715372 | 696192 | 685644 | 677046 | 673026 |